Fortrea Holdings Inc. (FTRE) Institutional Ownership & Insider Trading

333 institutions reported holding Fortrea Holdings Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 24 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

FTREFortrea Holdings Inc.Follow FTRE — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 2.2B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

333 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +0.2%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	333	100	+0.2%	93	32	101	33
Mar 26	327	100	+7.6%	109	35	71	46
Dec 25	341	95	-0.8%	92	42	94	32
Sep 25	321	96	-4.5%	66	42	106	53
Jun 25	333	100	+5.8%	98	52	88	70
Mar 25	348	94	-1.6%	95	55	97	51
Dec 24	342	95	-2.5%	72	42	117	54
Sep 24	344	98	-8.4%	65	26	135	65

Fortrea Holdings Inc. — questions

Who owns Fortrea Holdings Inc. stock?: 333 institutions reported Fortrea Holdings Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (16.6%), GOLDMAN SACHS GROUP INC (8.8%), Sessa Capital IM, L.P. (4.8%).
Are Fortrea Holdings Inc. insiders buying or selling?: 24 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Fortrea Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.